QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
OTCMKTS:BTHE

Boston Therapeutics Stock Forecast, Price & News

$0.0090
+0.00 (+5.88 %)
(As of 10/28/2020 11:43 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.01
52-Week Range
$0.01
Now: $0.01
$0.03
Volume19,400 shs
Average Volume31,291 shs
Market Capitalization$1.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Boston Therapeutics, Inc., a pre-clinical and clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements in the United States. Its lead pharmaceutical drug candidates include BTI-320, a non-systemic, carbohydrate-based compound that is in Phase IIb clinical trial to reduce post-meal elevation of blood glucose levels in Type 2 diabetic and pre diabetic patients; BTI-410, a peptide injectable compound that has completed Phase Ib clinical trials for type 1 immunosuppression therapy after kidney transplant surgery and type 2 diabetes patients; and IPOXYN, a carbohydrate-based, injectable drug to prevent necrosis, or cell death, as well as to treat hypoxic conditions, such as diabetic foot ulcers and other vascular/neurological complications. The company also develops OxyFex, an oxygen delivery agent for ischemia and trauma for blood loss during surgery in veterinary medicine applications. In addition, it produces and sells SUGARDOWN, a non-systemic complex carbohydrate-based dietary food supplement to support healthy post-meal blood glucose. The company was formerly known as Avanyx Therapeutics, Inc. and changed its name to Boston Therapeutics, Inc. in November 2010. Boston Therapeutics, Inc. was founded in 2009 and is headquartered in Lawrence, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BTHE
CUSIPN/A
Phone603-935-9799
Employees2

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20,000.00
Book Value($0.07) per share

Profitability

Miscellaneous

Market Cap$1.00 million
Next Earnings Date11/17/2020 (Estimated)
OptionableNot Optionable
$0.0090
+0.00 (+5.88 %)
(As of 10/28/2020 11:43 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BTHE News and Ratings via Email

Sign-up to receive the latest news and ratings for BTHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Boston Therapeutics (OTCMKTS:BTHE) Frequently Asked Questions

How has Boston Therapeutics' stock price been impacted by COVID-19?

Boston Therapeutics' stock was trading at $0.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BTHE stock has decreased by 10.0% and is now trading at $0.0090.
View which stocks have been most impacted by COVID-19
.

When is Boston Therapeutics' next earnings date?

Boston Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, November 17th 2020.
View our earnings forecast for Boston Therapeutics
.

How were Boston Therapeutics' earnings last quarter?

Boston Therapeutics Inc (OTCMKTS:BTHE) issued its quarterly earnings results on Monday, May, 14th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.01 million for the quarter.
View Boston Therapeutics' earnings history
.

Who are some of Boston Therapeutics' key competitors?

What other stocks do shareholders of Boston Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Therapeutics investors own include Dynavax Technologies (DVAX), NeXt Innovation (GSVC), InterCloud Systems (ICLD), Inpixon (INPX), PositiveID (PSID), Firsthand Technology Value Fund (SVVC), Arca Biopharma (ABIO), Acorn Energy (ACFN), Apollo Investment (AINV) and Ambarella (AMBA).

Who are Boston Therapeutics' key executives?

Boston Therapeutics' management team includes the following people:
  • Mr. Carl W. Rausch, CEO, CFO & Director (Age 70)
  • Dr. Meng Hee Tan, Consulting Medical Director

What is Boston Therapeutics' stock symbol?

Boston Therapeutics trades on the OTCMKTS under the ticker symbol "BTHE."

How do I buy shares of Boston Therapeutics?

Shares of BTHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Boston Therapeutics' stock price today?

One share of BTHE stock can currently be purchased for approximately $0.01.

How big of a company is Boston Therapeutics?

Boston Therapeutics has a market capitalization of $1.00 million and generates $20,000.00 in revenue each year. Boston Therapeutics employs 2 workers across the globe.

What is Boston Therapeutics' official website?

The official website for Boston Therapeutics is www.bostonti.com.

How can I contact Boston Therapeutics?

Boston Therapeutics' mailing address is 354 MERRIMACK STREET #4, LAWRENCE MA, 01843. The company can be reached via phone at 603-935-9799 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.